New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 21, 2014
07:37 EDTEWEdwards Lifesciences price target raised to $96 from $86 at Canaccord
Canaccord raised its price target on Edwards Lifesciences (EW) to $96 based on the worldwide patent litigation settlement with Medtronic (MDT). The firm believes the agreement removes an expensive distraction for the business and retains the goodwill of physicians. Shares are Buy rated.
News For EW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 23, 2015
11:20 EDTEWMedtronic competitive with Edwards after approval, says Wells Fargo
Subscribe for More Information
07:25 EDTEWPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
07:17 EDTEWFeedback on Edwards Lifesciences Centera 'very positive,' says Wells Fargo
Subscribe for More Information
June 17, 2015
19:14 EDTEWEdwards Lifesciences confirms FDA approval for SAPIEN 3 valve
Subscribe for More Information
15:29 EDTEWFDA approves SAPIEN 3 THV artificial heart valve
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use